Children’s Flonase offers 24-hour relief

PARSIPPANY, N.J. — In March, GSK Consumer Healthcare launched Children’s Flonase. If sales of the children’s liquid versions of existing allergy brands are any indication — typically pediatric SKUs represent between 10% and 25% the sales of their parent brand — Children’s Flonase could reach as high as $85 million in its first year.

(To view the full Category Review, click here.)



Children’s Flonase works differently from single-ingredient antihistamines, because it blocks six allergic substances instead of just one, GSK noted. It reduces inflammation and relieves allergy symptoms caused by pollen, mold spores, dust mites and pet dander.